Integra Lifesciences Holdings Corp reports results for the quarter ended in September - Earnings Summary

Integra LifeSciences Holdings

26/10/2022 14:32

* Integra Lifesciences Holdings Corp  IART.OQ  reported
quarterly
adjusted earnings of 86 cents​​ per share for the quarter ended
in September. The mean expectation of twelve analysts for the
quarter was for earnings of 72 cents per share.
    * Revenue fell 0.4% to $385.19 million from a year ago;
analysts
expected $378.32 million. 
    * Integra Lifesciences Holdings Corp's reported EPS for the
quarter was 60 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10.9%
in the last three months.​ 
    * In the last 30 days three analysts negatively revised
earnings
estimates 
    * Integra Lifesciences Holdings Corp shares had risen
by 5.3% this
quarter and lost 33.4% so far this year.
    * The company reported quarterly net income of $49.92
million.
    * Wall Street's median 12-month price target for Integra
Lifesciences Holdings Corp is $50.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 9
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data October
26 at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.72           0.86           Beat
 Jun. 30 2022      0.80           0.81           Beat
 Mar. 31 2022      0.68           0.74           Beat
 Dec. 31 2021      0.83           0.84           Beat